HPV vaccination of girls offers benefits to men but does not reduce risk of some cancers
the ONA take:
The association between human papillomavirus (HPV) and cervical cancer in women is well established.
Furthermore, vaccinating girls has had a positive impact on the incidence of cervical cancer in many countries in which the practice was adopted.
Men benefit indirectly from vaccinating girls in that their risk of contracting HPV is reduced; however, this does not protect men from cancers associated with the virus.
The HPV vaccine has been found effective in boys, but universal vaccination of boys is practiced in only a few countries (Australia, Austria, two Canadian provinces, and the United States).
Dutch researchers sought to estimate the benefit to men if boys were vaccinated against HPV, as well.
Their findings show that benefits from vaccinating boys would not be as significant as they are in girls. Therefore, the researchers suggest that programs for vaccinating girls should continue but including boys may be warranted.
Men benefit indirectly but not from cancer risk associated with the virus.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Open Hysterectomy Survival Rates Edge Minimally Invasive Procedures for Cervical Cancer
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|